Halometasone cream by day and halometasone ointment at night for the treatment of patients with chronic psoriasis vulgaris.

Abstract

In an open non-comparative trial forty-three hospitalized patients with chronic psoriasis vulgaris were treated with 0.05% halometasone cream (without dressing) by day and 0.05% halometasone ointment (with occlusive dressing) at night. This combined regimen yielded good to very good results in 93.1% of the patients treated. The trial treatment was fairly well tolerated, did not have any systemic adverse effects and had to be discontinued in only one patient, due to severe pustular eruption at the site of application.

• Authors: G Galbiati, V Bonfacini, F Candiani
• Journal: The Journal of international medical research (J Int Med Res) Vol. 11 Suppl 1 Pg. 31-3 ( 1983) ISSN: 0300-0605 [Print] England
• PMID: 6339290 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Anti-Inflammatory Agents
• Ointments
• Betamethasone
• halometasone

Topics

• Administration, Topical
• Adolescent
• Adult
• Aged
• Anti-Inflammatory Agents (administration & dosage, adverse effects)
• Betamethasone (administration & dosage, analogs & derivatives)
• Chronic Disease
• Clinical Trials as Topic
• Drug Administration Schedule
• Female
• Humans
• Male
• Middle Aged
• Ointments
• Psoriasis (drug therapy)